Posted by Michael Wonder on 24 Feb 2021
Inovise receives breakthrough device designation for novel non-invasive system to remotely monitor risk of decompensation in heart failure patients
23 February 2021 - Inovise Medical today announced the U.S. FDA has granted breakthrough device designation for its Audicor heart failure management system.
The system uses clinically tested algorithms to detect the risk of decompensation at home in patients who have been previously hospitalised for heart failure.
